Cargando…
Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints
Recently, multi-regional clinical trials (MRCTs), which incorporate subjects from many countries/regions around the world under the same protocol, have been widely conducted by many global pharmaceutical companies. The objective of such trials is to accelerate the development process for a drug and...
Autores principales: | Huang, Wong-Shian, Hung, Hui-Nien, Hamasaki, Toshimitsu, Hsiao, Chin-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493407/ https://www.ncbi.nlm.nih.gov/pubmed/28665972 http://dx.doi.org/10.1371/journal.pone.0180405 |
Ejemplares similares
-
Sample size determination in clinical trials with multiple endpoints
por: Sozu, Takashi, et al.
Publicado: (2015) -
Corrigendum: A logrank test-based method for sizing clinical trials with two
co-primary time-to-event endpoints (10.1093/biostatistics/kxs057)
por: Sugimoto, Tomoyuki, et al.
Publicado: (2016) -
Sample Size Determination for Individual Bioequivalence Inference
por: Chiang, Chieh, et al.
Publicado: (2014) -
Intratumor heterogeneity of lymphoma identified by multiregion sequencing of autopsy samples
por: Makishima, Kenichi, et al.
Publicado: (2021) -
Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
por: van Nistelrooij, Anna M. J., et al.
Publicado: (2017)